Revance Therapeutics (NASDAQ: RVNC)
Revance Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Revance Therapeutics Company Info
Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.
News & Analysis
Why Revance Therapeutics Stock Is Getting Crushed Today
A surprise rejection is weighing on the biopharma's shares today.
Why Revance Therapeutics Stock Is Bolting Higher Today
Management's response to a publicly disclosed regulatory form has investors doing a U-turn.
The FDA Accepted Revance Therapeutics' Application for Approval Of Its Botox Competitor
The company's frown line treatment moved closer to commercialization today.
Why Revance Therapeutics Stock Is Jumping 13.1% Today
A new deal accelerates the company's shift to a commercial-stage biotech.
Why Dynatrace, Revance Therapeutics, and Immunomedics Slumped Today
Several companies raised capital on Wednesday.
Here's Why Revance Therapeutics Stock Is Falling Today
The pricing of a secondary offering is to blame.
Why Hilton Grand Vacations, 21Vianet Group, and Revance Therapeutics Jumped Today
Possible merger and acquisition activity lifted one of these stocks.
Why Snap, Regal Entertainment Group, and Revance Therapeutics Jumped Today
Find out which of these stocks got a buyout bid.
Valuation
Earnings Transcripts
Revance Therapeutics Inc (RVNC) Q3 2021 Earnings Call Transcript
RVNC earnings call for the period ending September 30, 2021.
Revance Therapeutics (RVNC) Q1 2020 Earnings Call Transcript
RVNC earnings call for the period ending March 31, 2020.
Revance Therapeutics (RVNC) Q4 2019 Earnings Call Transcript
RVNC earnings call for the period ending December 31, 2019.
Revance Therapeutics (RVNC) Q3 2019 Earnings Call Transcript
RVNC earnings call for the period ending September 30, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.